The Luebeck interview for psychosocial screening in patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 13, Issue 1, 2007, Pages 33-41

  Jantschek, G ^a   Straubinger, K ^a   Heberlein, I ^a   Homann, N ^a   Ludwig, D ^a   Benninghoven, D ^a   Kunzendorf, Sebastian ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Anxiety; Depression; Impact of disease; Inflammatory bowel disease; psychosocial; LIPS; Social support

Indexed keywords

ADULT; ANXIETY; ARTICLE; COLITIS ACTIVITY INDEX; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DEPRESSION; DISEASE ACTIVITY; DISEASE COURSE; FEASIBILITY STUDY; FEMALE; HUMAN; INFLAMMATORY DISEASE; INTERRATER RELIABILITY; LUEBECK INTERVIEW FOR PSYCHOSOCIAL SCREENING; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOSOCIAL ENVIRONMENT; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SCREENING TEST; SELF REPORT; SOCIAL SUPPORT;

ADULT; ANXIETY; DEPRESSION; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL;

EID: 33846142514     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20050     Document Type: Article

References (51)

1. Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut. 2006;55(Suppl 1):i36-i58.
2. Lewis MC. Attributions and inflammatory bowel disease. Patient's perceptions of illness causes and the effects of these perceptions on relationships. AARN News Letter 1988;16.
3. Robertson D, Ray J, Diamond I, et al. Personality profile and affective state of patients with inflammatory bowel disease. Gut. 1989;30:623.
4. Maunder R. Mediators of stress effects in inflammatory bowel disease: not the usual suspects. J Psychosom Res. 2000;48:569-577.
5. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders. Clinician Version (SCID-CV). Washington, D.C.: American Psychiatric Press, Inc.; 1996.
6. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994;272:1749-1756.
7. Clarke DM, Smith GC, Dowe DL, et al. An empirically derived taxonomy of common distress syndromes in the medically ill. J Psychosom Res. 2003;54:323-330.
8. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res. 1997;42:17-41.
9. Drossman DA, Leserman J, Li ZM, et al. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med. 1991;53:701-712.
10. Irvine EJ, Zhou M, Thompson A, et al. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol. 1996;91:1571-1578.
11. Miehsler W, Weichselberger BS, Öfferlbauer-Ernst A, et al. Assessing the demand for psychological care in chronic diseases. Development and validation of a questionnaire based on the example of inflammatory bowel disease. Inflamm. Bowel Dis. 2004;10:637-645.
12. Andersen SM, Harthorn BH. The recognition, diagnosis and treatment of mental disorders by primary care physicians. Med Care. 1989;27:869-886.
13. Specht T, Benninghoven D, Jantschek G, et al. Psychosonziales Screening bei koronarer Herzkrankheit: fünf entscheidende Fragen. Zeitschrift für Kardiologie. 2002;91:S458-S465.
14. Benninghoven D, Specht T, Kunzendorf S, et al. The Luebeck Interview for Psychosocial Screening (LIPS). A validation study with patients suffering from coronary artery disease. Psychother Psych Med. 2003;53:267-274.
15. Benninghoven D, Kaduk A, Wiegand U, et al. The influence of anxiety on the course of heart disease after acute myocardial infarction: risk factor or protective function? Psychother Psychosom. 2006;75:56-61.
16. Benninghoven D, Kunzendorf S, Straubinger K, et al. The Luebeck Interview for Psychosocial screening (LIPS). Research Reports. Lübeck, Germany: University of Schleswig Holstein, Campus Lübeck, Department for Psychosomatic Medicine; 2004.
17. ENRICHD Investigators. Enhancing recovery in coronary heart disease patients (ENRICHD): Study design and methods. American Heart J. 2000;139:1-9.
18. Sommer G, Fydrich T. Soziale Unterstützung. Diagnostik, Konzepte, F-Sozu. Tübingen: Dt. Gesselschaft für Verhaltenstherapie; 1989.
19. Herrmann C, Buss U, Snaith RP. Hospital Anxiety and Depression Scale-German Version (HADS-D). Göttingen: Hogrefe Testzentrale: 1995.
20. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
21. Rose M, Fliege H, Hildebrandt M, et al. Validation of the new German translation version of the "Short Inflammatory Bowel Disease Questionnaire" (SIBDQ). Zeitschrift für Gastroenterologie 2000;38:277-286.
22. Petrak F, Börner N, Clement T, et al. The inflammatory Bowel Disease Stress Inventory (IBD-SI). A measure of psychosocial stress in patients with IBD. Psychother Psych Med. 2002;52:436-443.
23. Rachmilewitz D. Coated mesalazine versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298:82-86.
24. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's disease Study. Gastroenterol. 1976;70:439-444.
25. Rubin GP, Hungin AP, Chinn DJ, et al. Quality of life in patients with established inflammatory bowel disease: a UK general practice survey. Ailment Pharmacol Ther. 2004;19:529-535.
26. Guthrie E, Jackson J, Shaffer, et al. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol. 2002;97:1994-1999.
27. Nordin K, Pahlman L, Larsson K, et al. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J. Gastroenterol. 2002;37:450-457.
28. Helzer JE, Stilling WA, Chammas S, et al. A controlled study of the association between ulcerative colitis and psychiatric diagnosis. Dig Dis Sci. 1982;27:513.
29. Helzer JE, Chammas S, Norland CC, et al. A study of the association between Crohn's disease and psychiatric illness. Gastroenterology. 1984;86:324.
30. Tarter RE, Switala J, Carra J, et al. Inflammatory bowel disease: psychiatric status before and after disease onset. Int J Psychiatry Med. 1987;17:173.
31. Aronowitz R, Spiro HM. The rise and fall of the psychosomatic hypothesis in ulcerative colitis. J Clin Gastroenterol. 1988;10:298-305.
32. Casellas F, Lopez-Vivancos J, Badia X, et al. Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol. 2001;13:567-572.
33. Cohen RD. The quality of life in patients with Crohn's disease. Aliment Pharmacol Ther. 2002;16:1603-1609.
34. Guassora AD, Kruuse C, Thomsen OO, et al. Quality of life in a regional group of patients with Crohn's disease. A structured interview study. Scand J. Gastroenterol. 2000;35:1068-1074.
35. Drossman Da, Leserman J, Mitchell CM, et al. Health status and health care use in persons with inflammatory bowel disease: A national sample. Dig Dis Sci. 1991;36:1746.
36. Kurina LM, Goldacre MJ, Yeates D, et al. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health. 2001;55:716-720.
37. Porcelli P, Zaka S, Centonze S, et al. Psychological distress and levels of disease activity in inflammatory bowel disease. Ital J Gastroenterol. 1994;26:111-115.
38. Porcelli P, Leoci C, Guerra V. A prospective study of the relationship between disease activity and psychological distress in patients with inflammatory bowel disease. Scand J Gastroenterol. 1996;31:792-796.
39. Levenstein S, Prantera C, Varvo V, et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol. 1994;89:1219-1225.
40. Petrak F, Hardt J, Clement T, et al. Impaired health-related quality of life in inflammatory bowel disease; psychosocial impact and coping styles in a national German sample. Scand J Gastroenterol. 2001;36:375-382.
41. Küchenhoff J, Manz R, Mathes L. What modifies the course of Crohn disease (Was beeinfusst den Krankheitsverlauf des Morbus Crohn). Nervenarzt. 1995;66:41-48.
42. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18 month follow up study. Psychosom Med. 2004;66:79-84.
43. Mardini HE, Kip KE, Wilson JW. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci. 2004;49:492-497.
44. Sewitch MJ, Abrahamowicz M, Bitton A, et al. Psychological distress, social support and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:1470-1479.
45. Janke KH, Klump B, Gregor M, et al. Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:272-286.
46. Van der Eijk I, Vlachonikolis I, Munkholm P, et al. The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis. 2004;10:392-398.
47. Gomez-Gil E, Vidal A, Panes J, et al. Relationship between patient's subjective stress perception and the course of inflammatory bowel disease. Gastroenterol Hepatol. 2003;26:411-416.
48. Van-der-Zaag-Loonen HJ, Grootenhuis MA, Last BF, et al. Coping strategies and quality of life of adolescents with inflammatory bowel disease. Qual Life Res. 2004;13:1011-1019.
49. Mussell M, Blocker U, Nagel N, et al. Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2004;16:1273-1280.
50. Spitzer RL, Kroenke K, Williams J, et al. Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA. 1999;282:1737-1744.
51. Pallis AG, Vlachonikolis IG, Mouzas IA. Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece. BMC Gastroenterol. 2002;2:1.